How to Write a Prescription for Trelegy Ellipta
Write "Trelegy Ellipta" followed by the specific strength (100/62.5/25 mcg or 200/62.5/25 mcg), with directions for "one inhalation by mouth once daily" and dispense "1 inhaler (30 doses)" with appropriate refills.
Prescription Format
When writing for Trelegy Ellipta on a prescription pad, include these essential components:
Drug Name and Strength
- Brand name: Trelegy Ellipta
- Available strengths: 1
- 100/62.5/25 mcg (fluticasone furoate/umeclidinium/vilanterol)
- 200/62.5/25 mcg (fluticasone furoate/umeclidinium/vilanterol)
Complete Prescription Example
For COPD patients:
Trelegy Ellipta 100/62.5/25 mcg
Inhale one inhalation by mouth once daily
Disp: 1 inhaler (30 doses)
Refills: [as appropriate]For patients requiring higher ICS dose:
Trelegy Ellipta 200/62.5/25 mcg
Inhale one inhalation by mouth once daily
Disp: 1 inhaler (30 doses)
Refills: [as appropriate]Key Prescribing Details
Dosing Specifications
- Frequency: Once daily only 1
- Device: ELLIPTA dry powder inhaler 1
- Supply: Each inhaler contains 30 doses (60 blisters total - 2 strips of 30 blisters each) 1
- Discard date: 6 weeks after opening the foil tray 1
Important Prescribing Notes
Patient counseling points to document:
- Rinse mouth with water after each use and spit out (do not swallow) 1
- Not for acute symptoms or rescue use
- Contains lactose monohydrate with milk proteins 1
Common pitfall: Do not prescribe as "PRN" or "as needed" - this is a maintenance medication requiring once-daily dosing for optimal efficacy 2.
Strength Selection Algorithm
Choose 100/62.5/25 mcg when:
- Initiating triple therapy in most COPD patients
- Switching from low-to-medium dose ICS/LABA combinations
Choose 200/62.5/25 mcg when:
- Patient was previously on high-dose ICS combinations
- Inadequate symptom control on lower ICS dose
- Higher eosinophil counts or type 2 inflammation markers present 2